FDA Approved: CARDIOGEN-82 — Supplemental Application (Bracco Diagnostics Inc)

View source ↗

Summary

The FDA approved a supplemental application for CardioGen-82 (rubidium-82 chloride) submitted by Bracco Diagnostics Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Ischemic Heart Disease

Drugs mentioned

• CardioGen-82 (Rubidium chloride RB-82)

Snippet

SUPPL AP for CARDIOGEN-82 (RUBIDIUM CHLORIDE RB-82)